+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Saudi Arabia In Vitro Diagnostics (IVD) Market, Forecast by Segments, Applications, End User, Company Analysis

  • ID: 5331450
  • Report
  • May 2021
  • Region: Saudi Arabia
  • Renub Research

FEATURED COMPANIES

  • Abbott
  • Danaher Corporation
  • Roche
  • Siemens Healthineers
  • Sysmex Corporation
In-vitro diagnostics (IVD) plays a significant role in the Saudi Arabia healthcare system by providing accurate diagnosis and prognosis, thus enabling improved monitoring and treatment. Saudi Arabia represents the largest market for IVD in the GCC region. Diagnostics constitute a significant share of the total Kingdom’s healthcare spending. They are critical in medical decision-making and reducing diseases and healthcare expenditures. Saudi Arabia Health care Agenda, its vision of 2030 is to transform through diverse aspects, and one of the main areas of Vision 2030 is the healthcare sector. Ministry of Health plans and expenditure of 23 Billion SAR as new initiatives in the healthcare sector. According to the report, Saudi Arabia In Vitro Diagnostics Market is expected to reach US$ 1,400.92 Million by 2027.



There has been stable growth in the adoption of IVD in Saudi Arabia. Growing occurrence rates of different infectious and chronic diseases show some of the market's drivers in Saudi Arabia. Some of the other factors catalysing the growth of IVD in Saudi Arabia include rising healthcare expenditures, improving healthcare infrastructure, initiatives by the government, rising awareness levels, etc. As per our research findings, Saudi Kingdom IVD Market was valued US$ 866.74 Million in 2020.

Furthermore, due to the rising infectious diseases, cancer cases, and several people with diabetes in Saudi Arabia, it is believed that Saudi Arabia IVD Market will grow effortlessly in the coming years. Due to COVID-19 pandemic, all industry across the sector was impacted and so do Saudi Arabia IVD market. As per our study, this market would overcome during the forecast period. Looking forward, the publisher expects the Saudi Arabia IVD Industry to exhibit growth with a CAGR of 7.10% during 2020-2027.

By Segments - Immunochemistry is driving the Saudi Arabia IVD Market. Immunochemistry IVD devices have next-generation sequencing tests, which can help to sense genomic variation in person DNA. The growing old age population and increasing growth in the prevalence of chronic and infectious diseases are amongst the fundamental factors enhancing the growth and demand of the immunochemistry IVD market in Saudi Arabia.

By Disease type - Infectious hold significant Saudi Arabia IVD Market market, which is attributable to the rising incidence of infectious diseases such as HIV, AIDS, SARS-CoV-2, tuberculosis, and pneumonia. Besides, an increase in the development of infectious disease detection assays by market players for IVD is expected to drive the segment.

By End User - Government Hospitals & Laboratory holds the Largest Market. Most often, diagnostic centres collaborate with hospitals; hence, hospitals have their own diagnostic set up. Furthermore, the ongoing development of government healthcare infrastructure is anticipated to enhance the existing hospital facilities. Thus, the demand for Government Hospitals & Laboratory-based IVD tests is increasing.

The market for IVD in Saudi Arabia is moderately competitive, and major players are actively present in the country, promoting high product availability in Saudi Arabia. Among the top companies operating in the In-Vitro Diagnostics in Saudi Arabia, Roche, Abbott, Siemens Healthineers, Sysmex Corporation, and Danaher Corporation has been studied thoroughly in the report.

This report titled “Saudi Arabia In Vitro Diagnostics (IVD) Market, by Segments [Immunochemistry, Clinical Chemistry, Hematology, Hemostasis, Microbiology, Molecular Diagnostic, Self Monitoring of Blood Glucose (SMBG) and Point of Care Testing (POCT)]; by Applications (Infectious Diseases, Cardiovascular Diseases, Oncology, Diabetes and others); By End User (Government Labs & Hospitals, Private Labs & Hospitals and others) and by Companies (Roche, Abbott, Siemens Healthineers, Sysmex Corporation and Danaher Corporation)” provides a complete analysis of Saudi Arabia In-Vitro Diagnostics (IVD) Market.

Segments - Market have been covered from 8 viewpoints

1. Immunochemistry
2. Clinical Chemistry
3. Hematology
4. Hemostasis
5. Microbiology
6. Molecular Diagnostic
7. Self-Monitoring of Blood Glucose (SMBG)
8. Point of Care Testing (POCT)

Disease Type - Market has been covered from 5 viewpoints:

1. Infectious Diseases
2. Cardiovascular Diseases
3. Diabetes
4. Oncology
5. Others

End User - Market has been covered from 3 viewpoints:

1. Government Labs & Hospitals
2. Private Labs & Hospitals
3. Others

All companies have been covered from 3 viewpoints:
  • Overviews
  • Recent Developments
  • Revenues
Company Analysis:

1. Roche
2. Abbott
3. Siemens Healthineers
4. Sysmex Corporation
5. Danaher Corporation
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbott
  • Danaher Corporation
  • Roche
  • Siemens Healthineers
  • Sysmex Corporation
1. Introduction

2. Research Methodology

3. Executive Summary

4. Market Dynamics
4.1 Growth Drivers
4.2 Challenges

5. Saudi Arabia
5.1 Population
5.2 Per Capita Healthcare Expenses
5.3 Healthcare Expenditure

6. Saudi Arabia IVD Market

7. Market Share
7.1 By Segments
7.2 By Disease

8. Segments - Saudi Arabia IVD Market
8.1 Clinical Chemistry
8.2 Immunoassy
8.3 Molecular diagnostics
8.4 Hematology
8.5 Microbiology
8.6 Coagulation and Hemostasis
8.7 Urinalysis
8.8 Others

9. Disease Type - Saudi Arabia IVD Market
9.1 Infectious
9.2 Cardiology
9.3 Diabetes
9.4 Cancer/Oncology
9.5 Other Application

10. End Users - Saudi Arabia IVD Market
10.1 Public Labs& Hospitals
10.2 Private Labs& Hospitals
10.3 Others

11. Company Analysis
11.1 Roche Diagnostics
11.1.1 Overview
11.1.2 Company Initiatives
11.1.3 Sales Analysis
11.2 Abbott
11.2.1 Overview
11.2.2 Company Initiatives
11.2.3 Sales Analysis
11.3 Sysmex Corporation
11.3.1 Overview
11.3.2 Company Initiatives
11.3.3 Sales Analysis
11.4 Danaher Corporation
11.4.1 Overview
11.4.2 Company Initiatives
11.4.3 Sales Analysis
11.5 Thermo Fischer Scientific
11.5.1 Overview
11.5.2 Company Initiatives
11.5.3 Sales Analysis

List of Figures:
Figure-01: Saudi Arabia Population (Million), 2015 - 2020
Figure-02: Forecast for - Saudi Arabia Population (Million), 2021 - 2027
Figure-03: Saudi Arabia Per Capita on Healthcare Expenses (Per Capita US$), 2015 - 2020
Figure-04: Forecast for - Saudi Arabia Per Capita on Healthcare Expenses (Per Capita US$), 2021 - 2027
Figure-05: Saudi Arabia Per Capita on Healthcare Expenditure (Billion US$), 2015 - 2020
Figure-06: Forecast for - Saudi Arabia Per Capita on Healthcare Expenditure (Billion US$), 2021 - 2027
Figure-07: Saudi Arabia IVD Market (Billion US$), 2015 - 2020
Figure-08: Forecast for - Saudi Arabia IVD Market (Billion US$), 2021 - 2027
Figure-09: Segments - Clinical Chemistry Market (Million US$), 2015 - 2020
Figure-10: Segments - Forecast for Clinical Chemistry Market (Million US$), 2021 - 2027
Figure-11: Segments - Immunoassy Market (Million US$), 2015 - 2020
Figure-12: Segments - Forecast for Immunoassy Market (Million US$), 2021 - 2027
Figure-13: Segments - Molecular Diagnostics Market (Million US$), 2015 - 2020
Figure-14: Segments - Forecast for Molecular Diagnostics Market (Million US$), 2021 - 2027
Figure-15: Segments - Hematology Market (Million US$), 2015 - 2020
Figure-16: Segments - Forecast for Hematology Market (Million US$), 2021 - 2027
Figure-17: Segments - Microbiology Market (Million US$), 2015 - 2020
Figure-18: Segments - Forecast for Microbiology Market (Million US$), 2021 - 2027
Figure-19: Segments - Coagulation and Hemostasis Market (Million US$), 2015 - 2020
Figure-20: Segments - Forecast for Coagulation and Hemostasis Market (Million US$), 2021 - 2027
Figure-21: Segments - Urinalysis Market (Million US$), 2015 - 2020
Figure-22: Segments - Forecast for Urinalysis Market (Million US$), 2021 - 2027
Figure-23: Segments - Others Market (Million US$), 2015 - 2020
Figure-24: Segments - Forecast for Others Market (Million US$), 2021 - 2027
Figure-25: Disease - Infectious Market (Million US$), 2015 - 2020
Figure-26: Disease - Forecast for Infectious Market (Million US$), 2021 - 2027
Figure-27: Disease - Cardliology Market (Million US$), 2015 - 2020
Figure-28: Disease - Forecast for Cardliology Market (Million US$), 2021 - 2027
Figure-29: Disease - Diabetes Market (Million US$), 2015 - 2020
Figure-30: Disease - Forecast for Diabetes Market (Million US$), 2021 - 2027
Figure-31: Disease - Cancer/Oncology Market (Million US$), 2015 - 2020
Figure-32: Disease - Forecast for Cancer/Oncology Market (Million US$), 2021 - 2027
Figure-33: Disease - Other Application Market (Million US$), 2015 - 2020
Figure-34: Disease - Forecast for Other Application Market (Million US$), 2021 - 2027
Figure-35: End User - Public Labs & Hospitals Market (Million US$), 2015 - 2020
Figure-36: End User - Forecast for Public Labs & Hospitals Market (Million US$), 2021 - 2027
Figure-37: End User - Private Labs & Hospitals Market (Million US$), 2015 - 2020
Figure-38: End User - Forecast for Private Labs & Hospitals Market (Million US$), 2021 - 2027
Figure-39: End User - Others Market (Million US$), 2015 - 2020
Figure-40: End User - Forecast for Others Market (Million US$), 2021 - 2027
Figure-41: Roche Diagnostics - Global Revenue (Million US$), 2015 - 2020
Figure-42: Roche Diagnostics - Forecast for Global Revenue (Million US$), 2021 - 2027
Figure-43: Abbott - Global Revenue (Million US$), 2015 - 2020
Figure-44: Abbott - Forecast for Global Revenue (Million US$), 2021 - 2027
Figure-45: Sysmex Corporation - Global Revenue (Million US$), 2015 - 2020
Figure-46: Sysmex Corporation - Forecast for Global Revenue (Million US$), 2021 - 2027
Figure-47: Danaher Corporation - Global Revenue (Million US$), 2015 - 2020
Figure-48: Danaher Corporation - Forecast for Global Revenue (Million US$), 2021 - 2027
Figure-49: Thermo Fischer Scientific - Global Revenue (Million US$), 2015 - 2020
Figure-50: Thermo Fischer Scientific - Forecast for Global Revenue (Million US$), 2021 - 2027

List of Tables:
Table-01: Saudi Arabia IVD Market Share by Segments (Percent), 2015 - 2020
Table-02: Forecast for - Saudi Arabia IVD Market Share by Segments (Percent), 2021 - 2027
Table-03: Saudi Arabia IVD Market Share by Disease (Percent), 2015 - 2020
Table-04: Forecast for - Saudi Arabia IVD Market Share by Disease (Percent), 2021 - 2027
Note: Product cover images may vary from those shown
  • Roche
  • Abbott
  • Siemens Healthineers
  • Sysmex Corporation
  • Danaher Corporation
Note: Product cover images may vary from those shown

In this report, for analyzing the future trends for the studied market during the forecast period, the publisher has incorporated rigorous statistical and econometric methods, further scrutinized by secondary, primary sources and by in-house experts, supported through their extensive data intelligence repository. The market is studied holistically from both demand and supply-side perspectives. This is carried out to analyze both end-user and producer behavior patterns, in the review period, which affects price, demand and consumption trends. As the study demands to analyze the long-term nature of the market, the identification of factors influencing the market is based on the fundamentality of the study market.

Through secondary and primary researches, which largely include interviews with industry participants, reliable statistics, and regional intelligence, are identified and are transformed to quantitative data through data extraction, and further applied for inferential purposes. The publisher's in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of their recommendations and advice.

Primary Research

The primary purpose of this phase is to extract qualitative information regarding the market from the key industry leaders. The primary research efforts include reaching out to participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions. The publisher also established professional corporate relations with various companies that allow us greater flexibility for reaching out to industry participants and commentators for interviews and discussions, fulfilling the following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develop the analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth, and forecast

The researcher's primary research interview and discussion panels are typically composed of the most experienced industry members. These participants include, however, are not limited to:

  • Chief executives and VPs of leading corporations specific to the industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investment, and valuation experts
  • Key opinion leaders (KOLs)

Secondary Research

The publisher refers to a broad array of industry sources for their secondary research, which typically includes, however, is not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, webcasts, and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecasts
 

Loading
LOADING...

Adroll
adroll